Research against Cancer| Gustave Roussy

Information

Address

Gustave Roussy
114, rue Édouard-Vaillant
94805 Villejuif Cedex - France
Switchboard:

Switchboard

+33 (0)1 42 11 42 11
Emergency are dedicated to patients
treated at the Institute.
Emergency only: +33 (0)1 42 11 50 00

GUSTAVE ROUSSY
1st cancer center in Europe

ASCO Annual Meeting 2018

Find out Gustave Roussy's news at ASCO Annual Meeting 2018.

Learn more
Inventing the future today

Leading edge research to hasten major discoveries

Learn more
Clinical trials integrated into care

30% of patients included in a clinical trial at Gustave Roussy

Learn more
The great momentum of innovation

Innovations change the approach to the disease and prolong life. They are going to change all the parameters of treatment of cancer.

Read our manifesto for innovation
An integrated research

By bringing research and care together, Gustave Roussy implements therapeutic innovation.

Learn more
Specialised platforms

Gustave Roussy has eight technological platforms available to investigators

Learn more

Our research groups

Browse

News
Events

20/03/2019

Precision drug to stimulate immune system against some cancers

Gustave Roussy's researchers found an unkown ability to PARP inihibitors - a precision cancer drug used against breast and ovarian cancer - to stimulate the immune system. This study suggests to developp new combinaisons of treatments with immunotherapy.